Trials / Completed
CompletedNCT00927043
Study Evaluating Renal Cell Carcinoma Risk Factors
Prospective, Multicenter, Epidemiological Study To Determine The Clinical, Molecular And Genetic Factors Associated To The Prognosis Of Patients With Advanced Renal Cell Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 145 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an epidemiological, prospective, multicenter study designed to identify the pre-treatment clinical, molecular and genetic prognostic factors associated with progression free survival in patients naïve to renal cell carcinoma (RCC) treatment.
Detailed description
invitation to volunteer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Epidemiological study according to clinical practice | Epidemiological study according to clinical practice. |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2009-06-24
- Last updated
- 2011-11-07
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00927043. Inclusion in this directory is not an endorsement.